Gregory Fontana.

Leon, M.D.D.: Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.. Raj R. Makkar, M.D., Gregory Fontana, M.D., Hasan Jilaihawi, M.D., Tarun Chakravarty, M.D., Klaus F. Kofoed, M.D., D.M.Sc., Ole de Backer, M.D., Ph.D., Federico M. Asch, M.D., Carlos E. Ruiz, M.D., Niels T. Olsen, M.D., Ph.D., Alfredo Trento, M.D., John Friedman, M.D., Daniel Berman, M.D., Wen Cheng, M.D., Mohammad Kashif, M.D., Vladimir Jelnin, M.D., Chad A. Kliger, M.D., Hongfei Guo,…

According to researchers from Duke University in Durham.

In the study, 43 sufferers had been evaluated before using 3D MDCT angiography. In 40 of 43 individuals, surgical findings concurred with MDCT results, indicating that 3D MDCT can be an accurate method for imaging liver arteries prior to surgery, stated Erik K. Paulson, MD, an author on the paper. Previously, individuals underwent catheter angiography, diagnostic CT and an MRI aswell sometimes. Now, all the relevant imaging issues can be…

Actavis seeks FDA advertising acceptance for Ambrisentan Tablets.

Actavis' ANDA product is a generic edition of Gilead Sciences, Inc. Gilead Sciences, Inc. And Royalty Pharma Collection Trust filed suit against Actavis on April 1, 2015 in the U.S. District Courtroom for the District of Delaware wanting to prevent Actavis from commercializing its ANDA item before the expiration of U.S. Patent number RE42,462. The lawsuit was filed under the provisions of the Hatch-Waxman Act, producing a stay of last…

2 The benefits of clopidogrel in individuals with acute coronary syndromes.

Thus, it’s possible that the conversation was due to the play of chance. In conclusion, we found that in patients with an acute coronary syndrome who were referred for an early invasive strategy, there was no significant difference between a 7-day double-dose regimen of clopidogrel and standard-dose clopidogrel with respect to the main outcome of cardiovascular death, myocardial infarction, or stroke. There is also no significant difference between aspirin dosages…